Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06208709 · ClinicalTrials.gov registry record · NA
Carpal Arch Space Augmentation (CASA) Clinical Trial
A NA study of Carpal Tunnel Syndrome, sponsored by University of Arizona.
- Recruiting
- Registry status
- NA
- Development phase
- 116
- Enrollment target
- 1
- Study location
NCT06208709: Recruiting NA study of Carpal Tunnel Syndrome, sponsored by University of Arizona.
NCT06208709 is a NA study of Carpal Tunnel Syndrome that is actively recruiting participants, run by University of Arizona. The registered enrollment target is 116 participants, below the 217-participant average among 21 other Carpal Tunnel Syndrome trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06208709, a NA study of Carpal Tunnel Syndrome, is actively recruiting participants, sponsored by University of Arizona.
- RECRUITING
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
- 1
- Study location
Study Summary
This research proposes to evaluate the effectiveness of a novel device designed for the treatment of carpal tunnel syndrome. The device applies a small cyclic force to the wrist. The cycles include a small time period of force is applied, followed by a brief period of no force. The device is intended to be worn during hours of sleep. The efficacy of the treatment is evaluated based on patient reported outcomes. Treatment efficacy will also be evaluated based on comparisons to patient reported outcomes for a SOC treatment.
Primary Outcome
The BCTQ SSS is a validated, self-reported instrument used in the assessment of pain intensity for patients with carpal tunnel syndrome. Higher numbers are worse outcomes. Possible scores range from 1 ("normal", "no pain", or "without difficulty") to 5 ("very serious", "continued", "more than 5 times") Change = (Baseline score - week 8 score)
Conditions Studied
Interventions
- DEVICE carpal arch space augmentation (CASA)
- DEVICE standard of care (SOC)
Study Locations (1)
Arizona
- University of Arizona - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2024-04-23 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
What NCT06208709 shows while recruiting
NCT06208709 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 217-participant average among 21 other Carpal Tunnel Syndrome trials with a reported enrollment target (47% lower).
The record links to 1 condition, with Carpal Tunnel Syndrome appearing as the primary indexed condition, and to 2 interventions - of which carpal arch space augmentation (CASA) is the first listed.
NCT06208709 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT06208709 about?
NCT06208709 is a clinical study titled "Carpal Arch Space Augmentation (CASA) Clinical Trial". This research proposes to evaluate the effectiveness of a novel device designed for the treatment of carpal tunnel syndrome. The device applies a small cyclic force to the wrist. The cycles include a small time period of force is applied, followed by a brief period of no force. The device is intende...
What is the current status of trial NCT06208709?
This trial is currently recruiting. It is a NA study. The enrollment target is 116 participants. The study started on 2024-04-23. Estimated completion is 2026-07-31.
What conditions does trial NCT06208709 study?
This clinical trial studies the following conditions: Carpal Tunnel Syndrome.
What interventions are being tested in trial NCT06208709?
The interventions under investigation include: carpal arch space augmentation (CASA) (DEVICE), standard of care (SOC) (DEVICE).
Who is sponsoring clinical trial NCT06208709?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06208709 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carpal Tunnel Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06208709's enrollment target sits among peer trials
116 11th of 21 higher than 11 of 21 other Carpal Tunnel Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Carpal Tunnel Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Cooling Therapy for Post-Operative Pain in Open Carpal Tunnel Release
RECRUITING · NA
-
Small Nerve Fiber Activity in Patients with Carpal Tunnel Syndrome Assessed Via Quantitative Sensory Testing
RECRUITING · NA
-
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
RECRUITING · NA
-
Efficacy of Red Kinesiology Tape on Carpal Tunnel-Like Symptoms and Performance in Esports Gamers
RECRUITING · NA
-
Postoperative Care After Carpal Tunnel Release Using Short Educational Videos
ACTIVE NOT RECRUITING · NA
-
Post-operative Mobilization for Carpal Tunnel Syndrome
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI